Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

crop smart pty ltd - vegetable oil ester - emulsifiable concentrate - vegetable oil ester oil-plant extract active 700.0 g/l - adjuvant

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

victorian chemical company proprietary limited - vegetable oil ester - emulsifiable concentrate - vegetable oil ester oil-plant extract active 700.0 g/l - adjuvant - adjuvant | agricultural chemical additive | fungicide additive | herbicide additive | insecticide additive | activator | additiv - carrier - anti-evaporant | improve rain/fastness | reduce spray drift | adjuvant | evaporant | herbicide application | insecticide application | wetter

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - vegetable oil (emulsifiable) - emulsifiable concentrate - vegetable oil (emulsifiable) oil-plant extract active 835.0 g/l - adjuvant - agricultural chemical additive | foliar application | fungicide additive | herbicide additive | horticultural chemical additive - improve rain/fastness | spreader spray (refer to directions)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

loveland products inc - methyl esters of vegetable oil - emulsifiable concentrate - methyl esters of vegetable oil oil-plant active 630.0 g/l - adjuvant

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dksh agrisolutions pty ltd - nonionic surfactant blend; ammonium sulphate; vegetable oil ester - water dispersible granule - nonionic surfactant blend emulsifiers & surfactants active 105.0 g/kg; ammonium sulphate ammonium active 572.0 g/kg; vegetable oil ester oil-plant extract active 139.0 g/kg - adjuvant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - additive - refer to label | refer to glyphosate 450 g/l label

Australia - English - Department of Health (Therapeutic Goods Administration)

wellwisse pharmaceuticals pty ltd - vegetable oil phytosterol esters, quantity: 1000 mg - capsule, soft - excipient ingredients: soya oil; gelatin; glycerol; purified water; ascorbyl palmitate; mixed (low-alpha type) tocopherols concentrate; iron oxide red - maintain/support general health and wellbeing ; helps reduce intestinal absorption of cholesterol from dietary sources ; helps maintain/support healthy cholesterol

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1. progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2. undiagnosed abnormal genital bleeding. 3. known, suspected, or history of breast cancer. 4. active deep vein thrombosis, pulmonary embolism or history of these conditions. 5. active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6. known liver dysfunction or disease. 7. known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

dr. reddy’s laboratories, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1. progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2. undiagnosed abnormal genital bleeding. 3. known, suspected, or history of breast cancer. 4. active deep vein thrombosis, pulmonary embolism or history of these conditions. 5. active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6. known liver dysfunction or disease. 7. known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals llc - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone capsules should not be used in women with any of the following conditions: 1.      progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts. 2.      undiagnosed abnormal genital bleeding. 3.      known, suspected, or history of breast cancer. 4.      active deep vein thrombosis, pulmonary embolism or history of these conditions. 5.      active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions. 6.      known liver dysfunction or disease. 7.      known or suspected pregnancy.

United States - English - NLM (National Library of Medicine)

virtus pharmaceuticals - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 100 mg - progesterone, usp capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone, usp capsules should not be used in women with any of the following conditions: